Additively manufactured articles having passivated surfaces and related methods

Additive manufacturing with magnesium components and a magnesium fluoride passivation layer addresses the challenge of producing complex, seamless 3D articles with improved structural integrity and resistance for semiconductor and medical applications.

JP2024541806AInactive Publication Date: 2024-11-13ENTEGRIS INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2024519326
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-04-28
Filing Date
2022-09-22
Publication Date
2024-11-13
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Machining processes cannot produce devices with complex shapes as a single part, leading to seams or welds when multiple parts are assembled, which compromises structural integrity.

Method used

Additive manufacturing is used to create 3D articles with magnesium components, followed by a vapor phase fluorination process to form a passivation layer of magnesium fluoride, ensuring a monolithic structure without seams or welds.

Benefits of technology

The method enables the production of complex, seamless 3D articles with enhanced corrosion and etch resistance, suitable for semiconductor tools and medical devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541806000001_ABST
    Figure 2024541806000001_ABST
Patent Text Reader

Abstract

Some embodiments relate to additively manufactured articles having a passivated surface and related methods. The method may include forming a three-dimensional (3D) article by additive manufacturing to obtain an additively manufactured 3D article comprising a magnesium component. The method may further include exposing the additively manufactured 3D article to a reactive gas phase comprising a fluorine component. The fluorine component from the reactive gas phase may react with the magnesium component of the additively manufactured 3D article to form a passivation layer on and under the surface of the additively manufactured 3D article.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates generally to additively manufactured articles having passivated surfaces and related methods. [Background technology]

[0002] Machining processes do not allow for the manufacture of devices (or device portions) having complex geometries as a single piece. For example, devices having complex geometries can only be manufactured by assembling multiple parts. The assembly of multiple parts often results in a seam or weld formed at the interface of two or more parts. Summary of the Invention

[0003] In a first aspect, a method for forming an article is disclosed, the method comprising: forming a three-dimensional (3D) article by additive manufacturing to obtain an additively manufactured 3D article, where the additively manufactured 3D article comprises a magnesium component; and exposing the additively manufactured 3D article to a reactive gas phase to form a passivation layer, where the reactive gas phase comprises a fluorine component, where the fluorine component reacts with the magnesium component to form magnesium fluoride at and below the surface of the additively manufactured 3D article.

[0004] A second embodiment according to the first embodiment, wherein the forming includes dispensing 3D printable material from a 3D printer to form the additively manufactured 3D article.

[0005] A third embodiment according to the first or second embodiment, wherein the magnesium component comprises at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

[0006] A fourth embodiment according to any one of the first to third embodiments, wherein the additively manufactured 3D article has a monolithic structure that cannot be constructed by machining.

[0007] A fifth embodiment according to any one of the first to fourth embodiments, wherein the additively manufactured 3D article is an article of unitary construction.

[0008] A sixth aspect according to any one of the first to fifth aspects, wherein the additively manufactured 3D article includes at least one of a plenum, a groove, a structure defining a hole, a structure defining a channel, a structure defining a cavity, or any combination thereof.

[0009] A seventh embodiment according to any one of the first to sixth embodiments, wherein the additively manufactured 3D article has an aspect ratio of 2:1 to 1000:1, the aspect ratio being the ratio of two of the width, depth, height, or diameter.

[0010] An eighth embodiment according to any one of the first to seventh embodiments, wherein the additively manufactured 3D article does not include a seam.

[0011] A ninth embodiment according to any one of the first to eighth embodiments, wherein the additively manufactured 3D article does not include a brazed joint.

[0012] A tenth embodiment according to any one of the first to ninth embodiments, wherein the additively manufactured 3D article does not include a welded joint.

[0013] An eleventh embodiment according to any one of the first to tenth embodiments, wherein the reactive gas phase comprises at least one of CF4, C2F4, C3F6, C4F8, CHF3, C2H2F2, C2F6, HF, CH3F, or any combination thereof.

[0014] The reactive gas phase is C1-C 10A twelfth embodiment according to any one of the first to eleventh embodiments, derived from at least one of: polymerized perfluoroalkyl ethylene having a perfluoroalkyl group; polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

[0015] A thirteenth embodiment according to any one of the first to twelfth embodiments, wherein the magnesium fluoride covers at least 90% of a gas exposed surface of the additively manufactured 3D article.

[0016] In a fourteenth aspect, a component of a semiconductor manufacturing tool is disclosed that includes an article formed by the methods disclosed herein.

[0017] In a fifteenth aspect, a medical device is disclosed that includes an article formed by the methods disclosed herein.

[0018] In a sixteenth aspect, an article is disclosed that includes: an additively manufactured three-dimensional (3D) body, where the additively manufactured 3D body comprises a magnesium component, where the additively manufactured 3D body has a monolithic structure that is not buildable by machining; and a surface and subsurface passivation layer of the additively manufactured 3D body, where the passivation layer comprises magnesium fluoride, where the magnesium fluoride is a reaction product of the magnesium component and a fluorine component from a reactive gas phase.

[0019] A seventeenth aspect according to the sixteenth aspect, wherein the additively manufactured 3D article includes at least one of a plenum, a groove, a structure defining a hole, a structure defining a channel, a structure defining a cavity, or any combination thereof.

[0020] An 18th embodiment according to the 16th or 17th embodiment, wherein the additively manufactured 3D article has an aspect ratio of 2:1 to 1000:1, the aspect ratio being the ratio of two of the width, depth, height, or diameter.

[0021] A 19th embodiment according to any one of the 16th to 18th embodiments, wherein the additively manufactured 3D article is a monolithically constructed article.

[0022] A twentieth aspect according to any one of the sixteenth to nineteenth aspects, wherein the additively manufactured 3D article does not include a seam, does not include a brazed joint, and does not include a welded joint.

[0023] In a twenty-first aspect, a medical device is disclosed, the medical device comprising: an additively manufactured three-dimensional (3D) body, the additively manufactured 3D body comprising a magnesium component; and a surface and subsurface passivation layer of the additively manufactured 3D body, the passivation layer comprising magnesium fluoride, the magnesium fluoride being a reaction product of the magnesium component and a fluorine component from a reactive gas phase.

[0024] A twenty-second embodiment according to the twenty-first embodiment, wherein the medical device is configured to be implanted in a mammal.

[0025] A twenty-third embodiment according to the twenty-first embodiment, wherein the medical device is configured for temporary insertion into the mammal.

[0026] A twenty-fourth embodiment according to the twenty-first embodiment, wherein the medical device is configured for external application in a mammal.

[0027] A 25th embodiment according to any one of the 21st to 24th embodiments, wherein the additively manufactured 3D body is biocompatible.

[0028] A 26th aspect according to any one of the 21st to 25th aspects, wherein the additively manufactured 3D body is a body of a medical device.

[0029] A 27th aspect according to any one of the 21st to 25th aspects, wherein the additively manufactured 3D body is a part of a medical device.

[0030] A 28th embodiment according to any one of the 21st to 27th embodiments, wherein the additively manufactured 3D body is at least one of a balloon, a graft, a stent, a catheter, a shunt, an embolic agent, a pacemaker, a defibrillator, an artificial implant, a prosthesis, a stimulator, a sensor, a wire, a lead, a valve, a plug, a pump, a filter, a mechanical connector, a tube, a plate, a surgical instrument, a housing, any part thereof, or any combination thereof.

[0031] A 29th embodiment according to any one of the 21st to 28th embodiments, wherein the additively manufactured 3D body is at least one of an angioplasty balloon, a valvuloplasty balloon, a placement balloon, a pacemaker lead, a prosthetic heart valve, a vascular filter, a vascular plug, an artificial heart valve, an artificial heart, a catheter tip, a suture, a surgical stapler, a screw, a nail, a bracket, a pin, a rod, a fixator, a guidewire, a drug pump, a synthetic vascular graft, a vascular graft, a non-vascular graft, a stent graft, a vascular stent, a coronary stent, a peripheral stent, an intraluminal paving stent, an arteriovenous shunt, an aneurysm filling, an implantable pulse generator, an implantable cardiac defibrillator, an electrical defibrillator, a spinal cord stimulator, a brain stimulator, a sacral nerve stimulator, a bone prosthesis, a joint prosthesis, a plastic tube, a metal tube, a dental appliance, a hearing aid, a bandage, any part thereof, or any combination thereof.

[0032] A 30th embodiment according to any one of the 21st to 29th embodiments, wherein the additively manufactured 3D body comprises a structure having an aspect ratio between 2:1 and 1000:1.

[0033] A thirty-first embodiment according to the thirtieth embodiment, wherein the aspect ratio is a ratio of two of the width, depth, height, or diameter.

[0034] A thirty-second embodiment according to any one of the twenty-first to thirty-first embodiments, wherein the magnesium component comprises at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

[0035] A thirty-third embodiment according to any one of the twenty-first to thirty-second embodiments, wherein the additively manufactured 3D body has a monolithic structure that is not buildable by machining.

[0036] A thirty-fourth embodiment according to any one of the twenty-first to thirty-third embodiments, wherein the additively manufactured 3D body is an article of monolithic construction.

[0037] A thirty-fifth aspect according to any one of the twenty-first to thirty-fourth aspects, wherein the additively manufactured 3D body does not include a seam.

[0038] A thirty-sixth aspect according to any one of the twenty-first to thirty-fifth aspects, wherein the additively manufactured 3D body does not include a brazed joint.

[0039] A thirty-seventh aspect according to any one of the twenty-first to thirty-sixth aspects, wherein the additively manufactured 3D body does not include a welded joint.

[0040] A thirty-eighth embodiment according to any one of the twenty-first to thirty-seventh embodiments, wherein the reactive gas phase comprises at least one of CF4, C2F4, C3F6, C4F8, CHF3, C2H2F2, C2F6, HF, CH3F, or any combination thereof.

[0041] The reactive gas phase is C1-C 10A thirty-ninth embodiment according to any one of the twenty-first to thirty-eighth embodiments, derived from at least one of: polymerized perfluoroalkyl ethylene having a perfluoroalkyl group; polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

[0042] Reference is made to the drawings which form a part of this disclosure and which illustrate embodiments in which the materials and methods described herein may be practiced. [Brief description of the drawings]

[0043] [Figure 1] FIG. 1 is a flow diagram of a method for forming an article according to some embodiments of the present disclosure. [Diagram 2] 1 is a schematic diagram of a cross-section of an article according to some embodiments of the present disclosure. [Diagram 3] 1 is a schematic diagram of a cross-section of an article according to some embodiments of the present disclosure. [Figure 4] 1 is an image of an additively manufactured article prior to passivating a surface of the additively manufactured article, according to some embodiments of the present disclosure. [Diagram 5] 5 is an image of the additively manufactured article of FIG. 4 after passivating a surface of the additively manufactured article, according to some embodiments of the present disclosure. [Figure 6] FIG. 2 is a graph of Energy Dispersive X-ray Spectroscopy (EDS) according to some embodiments of the present disclosure. [Figure 7] FIG. 2 is a graph of Energy Dispersive X-ray Spectroscopy (EDS) according to some embodiments of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0044] The embodiments of the present disclosure relate, inter alia, to articles formed by additive manufacturing, methods for forming articles by additive manufacturing, applications including articles formed by additive manufacturing, and related embodiments. Some embodiments of the present disclosure relate to additively manufactured articles having one or more passivated surfaces. In some embodiments, an article formed by additive manufacturing may have at least one of a monolithic structure, one or more high aspect ratio features, or any combination thereof. In some embodiments, after fabricating an article by additive manufacturing, the article may be subjected to a vapor phase fluorination process in which one or more surfaces of the additively manufactured article are passivated with magnesium fluoride. In some embodiments, the vapor phase fluorination process is sufficient to passivate all exposed surfaces of the additively manufactured article. In some embodiments, the passivated surface of the additively manufactured article provides at least one of a corrosion resistant layer, an etch resistant layer, or any combination thereof.

[0045] 1 is a flow diagram of a method for forming an article according to some embodiments of the present disclosure. As shown in FIG. 1, the method 100 for forming an article may include one or more of the following steps: forming a three-dimensional (3D) article by additive manufacturing 102, and exposing the 3D article to a gas phase reactant to form a passivation layer 104.

[0046] In step 102, the method 100 may include forming a 3D article by additive manufacturing. In some embodiments, additive manufacturing may include 3D printing. In some embodiments, the 3D article is formed by dispensing 3D printable material from a 3D printer to form the 3D article. In some embodiments, 3D printing may include creating a solid object from a 3D model by building the object in stages. In some embodiments, for example, 3D printing may include applying 3D printable material in layers that are selectively bonded or fused together to create a 3D article having at least one of a monolithic structure, a one-piece build, a structure that cannot be built by machining, or any combination thereof. The 3D printing may be performed using at least one of the following: selective laser melting (SLM), selective laser sintering (SLS), fused deposition modeling (FDM), electron beam melting (EBM), direct metal laser sintering (DMLS), or any combination thereof.

[0047] In some embodiments, the 3D article may be formed from a precursor material. In some embodiments, the precursor material may include, consist of, or consist essentially of a 3D printable material. In some embodiments, the precursor material may include a raw material, such as a granular raw material. For example, in some embodiments, the precursor material may include at least one of a metal powder, a metal alloy powder, a ceramic powder, a polymer (e.g., a photopolymer resin, a thermoplastic polymer, or any combination thereof), or any combination thereof. In some embodiments, the precursor material may include a material that can be fused by heat (e.g., a scanning laser or a scanning electron beam). In some embodiments, the precursor material may include, consist of, or consist essentially of a metallic component. In some embodiments, the metallic component may include, consist of, or consist essentially of at least one of one or more metals, one or more metal compounds, one or more metal oxides, one or more metal alloys, or any combination thereof. In some embodiments, the precursor materials are: Al, Mg, Ni, Ti, V, Fe, Cr, Zn, Mo, Li, Cu, Mn, In, Sn, P, Sb, As, Bi, Pb, Te, Se, W, Ge, Cd, Co, Ag, Pt, Hg, Ir, Os, S, K, Ga, Na, Nb, Ta, Si, La2O3, NiO, Fe2O3, Al2O3, BaO, MgO, CaO, HfO2, ZrO2, SnO2 , In2O3, KO, CeO2, Ce2O3, Sc2O3, Y2O3, Ga2O3, Na2O, BO, SrO, BeO, titanium oxide, tantalum oxide, niobium oxide, silicon carbide, stainless steel, rare earth oxides, components thereof, or any combination thereof. In some embodiments, the precursor material may include one or more solvents.

[0048] In some embodiments, the 3D article may include at least a magnesium component. The magnesium component may include magnesium in a mobile form. For example, in some embodiments, the magnesium component may include magnesium in metallic form as a metal alloy, a metal ion, a metal oxide, elemental magnesium, or any combination thereof. In some embodiments, the magnesium component includes at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

[0049] In some embodiments, the 3D article may include an additively manufactured 3D article. In some embodiments, the 3D article may include an additively manufactured 3D body. In some embodiments, the 3D article may have a monolithic structure. In some embodiments, the monolithic structure may be a structure that cannot be constructed by machining. In some embodiments, the term "machining" may refer to a process of shaping a material by, for example, but not limited to, milling, drilling, grinding, cutting, engraving, chipping, or forming, among others. In some embodiments, the monolithic structure may be a structure that is integrally constructed. In some embodiments, the 3D article may be integrally constructed. In some embodiments, the term "integrally constructed" may refer to a structure that does not include two or more structures that are joined together after fabrication. For example, in some embodiments, the 3D article may not include any structures that are fabricated separately and then joined together. In some embodiments, the integrally constructed monolithic structure may be at least one of a structure that does not include seams, a structure that does not include brazed joints, a structure that does not include welded joints, or any combination thereof.

[0050] In some embodiments, the 3D article may have at least one feature. The at least one feature may include, consist of, consist essentially of, or be selected from the group consisting of a plenum, a groove, a structure defining a hole, a structure defining a channel, a structure defining a cavity (e.g., a partially enclosed region defining a cavity), a planar surface, a non-planar surface, or any combination thereof. In some embodiments, the at least one feature may have an aspect ratio. For example, in some embodiments, the aspect ratio of a feature may refer to the ratio of depth to width. In some embodiments, the aspect ratio of a feature may refer to the ratio of width to depth. In some embodiments, the aspect ratio of a feature may refer to the ratio of two of length, width, or height. In some embodiments, the aspect ratio of a feature may refer to the ratio of depth to diameter. In some embodiments, the aspect ratio of a feature may refer to the ratio of diameter to depth. In some embodiments, the aspect ratio of a feature may refer to the ratio of at least two of the following: width, depth, height, diameter, and circumference.

[0051] In some embodiments, at least one feature may have an aspect ratio of 2:1 to 1000:1, or any range or subrange therebetween. For example, at least one feature may have an aspect ratio of at least 2:1, at least 3:1, at least 4:1, at least 5:1, at least 6:1, at least 7:1, at least 8:1, at least 9:1, at least 10:1, at least 15:1, at least 20:1, at least 25:1, at least 30:1, at least 35:1, at least 40:1, at least 45:1, at least 50:1, at least 55:1, at least 60:1, at least 65:1, at least 70:1, at least 75:1, at least 80:1, at least 85:1, at least 90:1, at least 95:1, at least 100:1, at least 200:1, at least 300:1, at least 400:1, at least 500:1, at least 600:1, at least 700:1, at least 800:1, at least 900:1 to 1000:1, and / or any range or sub-range therebetween.

[0052] In some embodiments, the 3D article may be a part of a semiconductor manufacturing tool, such as, but not limited to, at least one of a process chamber, a sidewall, a flow head (e.g., a shower head), a shield, a tray, a support, a nozzle, a valve, a conduit, a stage for handling or holding an object, a wafer handling fixture, a wafer carrier, a wafer holder, a susceptor, a spindle, a chuck, a ring, a baffle, a fastener (e.g., a (threaded) screw, a (threaded) nut, a bolt, a clamp, a rivet, etc.), a membrane, a filter, a three-dimensional network, a conduit (e.g., a gas line), a manifold (e.g., a gas manifold), a window, an injector, a liner, a manifold, or any combination thereof. The magnesium fluoride passivation layer may be biocompatible such that the 3D article may be useful as an implantable medical device or any part thereof. For example, in other embodiments, the 3D article may be a medical device or part of a medical device, such as, but not limited to, at least one of a medical instrument, a medical implant, or an article having a medical application. Non-limiting examples of medical devices and / or parts thereof include at least one of a prosthesis (e.g., knee, joint, shoulder, hip, etc.), dental appliance, hearing aid, orthotic, nail, screw, plate, catheter, tube, valve, housing, wire, stent, connector, or any combination thereof, and the like.

[0053] In step 104, in some embodiments, the 3D article may be exposed to a reactive gas phase to form a passivation layer. In some embodiments, the exposure may be performed under conditions sufficient to result in the formation of a passivation layer. In some embodiments, the exposure may be performed in a chamber configured to expose the reactive gas phase to the 3D article. In some embodiments, the exposure may be performed in a process chamber. In some embodiments, the exposure may be performed in a reactor. In some embodiments, the exposure may be performed by vaporizing a solid or liquid precursor material to obtain a reactive gas phase. In some embodiments, the solid or liquid precursor material is vaporized in a reactor or process chamber; or in a separate vessel, and then the reactive gas phase is provided to the process chamber or reactor. In some embodiments, the exposure may be performed by providing a reactive gas phase to a process chamber or reactor (e.g., without vaporizing a solid or liquid precursor material to obtain a reactive gas phase). In some embodiments, the passivation layer is formed by a deposition process that does not use a plasma. In some embodiments, the passivation layer is formed by a non-plasma deposition process.

[0054] In some embodiments, the reactive gas phase may include a fluorine component. In some embodiments, the reactive gas phase may include a molecular fluorine source vapor, which may be derived from a liquid or solid. In some embodiments, the fluorine component may include, consist of, or consist essentially of molecular fluorine. In some embodiments, the fluorine component is non-ionic, substantially non-ionic, not treated to form a plasma (e.g., by applying energy other than heat), or any combination thereof. In some embodiments, the fluorine component may include, consist of, or consist essentially of at least one of a fluorinated organic compound, a perfluorinated organic compound, or any combination thereof. In some embodiments, for example, the fluorine component may include, consist of, or consist essentially of at least one of a fluorinated alkane, a perfluorinated alkane, a fluorinated alkene, a perfluorinated alkene, or any combination thereof (any one or more of which may be linear or branched). In some embodiments, the fluorine component may be selected from the group comprising, consisting of, consisting essentially of, or consisting of at least one of CF4, C2F4, C3F6, C4F8, CHF3, C2H2F2, C2F6, HF, CH3F, or any combination thereof. In some embodiments, the reactive gas phase is different from the plasma, the process for generating the plasma, or any combination thereof.

[0055] In some embodiments, the reactive gas phase may include a gaseous fluorinated polymer derived from a non-gaseous fluorinated polymer (e.g., a solid or liquid phase fluorinated polymer). In some embodiments, the fluorinated polymer may be a homopolymer or a copolymer. In some embodiments, the fluorinated polymer may include a copolymer of at least one fluoroolefin monomer and, optionally, at least one non-fluorinated comonomer. In some embodiments, the fluorinated polymer may be fluorinated (i.e., partially fluorinated), fully fluorinated, or may include non-fluorine halogen atoms, such as, but not limited to, chlorine. In some embodiments, the molecular fluorine source may be a liquid or solid at room temperature, but vaporizes at the process temperatures disclosed herein. Non-limiting examples of fluoropolymers include, but are not limited to, the following: C1-C 10 At least one of polymerized perfluoroalkyl ethylene having a perfluoroalkyl group; polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

[0056] In some embodiments, the passivation layer may include magnesium fluoride (MgF2). In some embodiments, the magnesium fluoride of the passivation layer may be a reaction product between a magnesium component present in the 3D article and a fluorine component present in the reactive gas phase. In some embodiments, the magnesium fluoride of the passivation layer may be formed on the surface of the 3D article and below the surface of the 3D article. For example, in some embodiments, the fluorine component may react with at least one of magnesium present on the surface of the 3D article, magnesium present below the surface of the 3D article, magnesium diffusing or migrating from a bulk portion of the 3D article to the surface or an area adjacent to the surface, or any combination thereof. In some embodiments, the passivation layer may not be a substantially separate layer formed on the surface of the 3D article, but rather a region formed on the surface of the 3D article and optionally below the surface. In some embodiments, the passivation layer is not (and therefore is distinct from) a layer applied to the 3D article surface by a coating process or deposition process (e.g., chemical vapor deposition, atomic layer deposition, physical vapor deposition, etc.). In some embodiments, the term passivation layer may refer to a passivation region on a surface of a 3D article (e.g., formed on the surface of the 3D article, and optionally below the surface). In some embodiments, unless otherwise indicated, the term passivation layer may be used interchangeably with the term passivation region.

[0057] In some embodiments, the passivation layer may comprise, consist of, or consist essentially of at least one of magnesium compounds, fluoride compounds, magnesium fluoride compounds, oxide compounds, metal compounds, metal oxide compounds, or any combination thereof. In some embodiments, the passivation layer may comprise, consist of, or consist essentially of at least one of magnesium fluoride (MgF2), metal oxide compounds, or any combination thereof. In some embodiments, the metal oxide compounds may be reaction products. For example, in some embodiments, the metal oxide compounds may be formed when the 3D article is exposed to oxygen.

[0058] In some embodiments, an atomic layer deposition (ALD) coating may optionally be disposed on the passivation layer (e.g., on a surface of the passivation layer). In some embodiments, the ALD coating may include yttria. In some embodiments, the ALD coating may include zirconia. In some embodiments, the ALD coating may include titania. In some embodiments, the ALD coating may include AlO x N y where x is 1 to 5 and N is 1 to 5. In some embodiments, the ALD coating may be on a surface of a 3D article.

[0059] In some embodiments, the exposure may be at one or more process conditions. The process conditions may include at least one of temperature, pressure, duration, or a combination thereof. In addition, the process conditions should be sufficient to cause the fluorine of the fluorine component to react with the magnesium present in the 3D article to form magnesium fluoride (MgF2). For example, in some embodiments, the process conditions may be at a temperature, pressure, duration, or any combination thereof sufficient to cause the fluorine of the fluorine component to react with the magnesium present in the 3D article to form MgF2. The process conditions may be varied or adjusted to obtain at least one of a predetermined thickness, a predetermined coverage, a predetermined property (e.g., at least one of corrosion resistance, etch resistance, or any combination thereof), or any combination thereof.

[0060] In some embodiments, the exposure may occur at a temperature between 200° C. and 500° C., or any range or subrange therebetween. For example, in some embodiments, the exposure occurs at a temperature between 250° C. and 500° C., 300° C. and 500° C., 350° C. and 500° C., 400° C. and 500° C., 450° C. and 500° C., 200° C. and 400° C., 200° C. and 450° C., 200° C. and 350° C., 200° C. and 300° C., 200° C. and 250° C., 375° C. and 425° C., 375° C. and 450° C., 400° C. and 425° C., 400° C. and 450° C., and / or any range or subrange therebetween.

[0061] In some embodiments, the exposure is at a pressure between 100 Torr and 1500 Torr, or any range or subrange therebetween. For example, in some embodiments, the exposure is at a pressure between 200 Torr and 1500 Torr, 300 Torr and 1500 Torr, 400 Torr and 1500 Torr, 500 Torr and 1500 Torr, 600 Torr and 1500 Torr, 700 Torr and 1500 Torr, 800 Torr and 1500 Torr, 900 Torr and 1500 Torr, 1000 Torr and 1500 Torr, 1100 Torr and 1500 Torr, 1200 Torr and 1500 Torr, 1300 Torr and 1500 Torr, 1400 Torr and 1500 Torr, 100 Torr and 1400 Torr, 100 Torr and 1300 Torr , 100 Torr to 1200 Torr, 100 Torr to 1100 Torr, 100 Torr to 1000 Torr, 100 Torr to 900 Torr, 100 Torr to 800 Torr, 100 Torr to 700 Torr, 100 Torr to 600 Torr, 100 Torr to 500 Torr, 100 Torr to 400 Torr, 100 Torr to 300 Torr, 100 Torr to 200 Torr, 250 Torr to 1000 Torr, 500 Torr to 1000 Torr, 250 Torr to 1250 Torr, 500 Torr to 1250 Torr, and / or any range or sub-range therebetween.

[0062] In some embodiments, the exposure is for a period of 1 hour to 15 hours, or any range or subrange therebetween, for example, in some embodiments, the exposure is for a period of 2 hours to 13 hours, for a period of 3 hours to 12 hours, and / or any range or subrange therebetween.

[0063] In some embodiments, surface coverage may refer to the percentage of the exposed surface (e.g., gas-exposed surface) that comprises magnesium fluoride. In some embodiments, exposed surface may also refer to an unmasked surface. In some embodiments, surface coverage may be at least 80%-100%, or any range or subrange therebetween. For example, in some embodiments, surface coverage may be at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%. In some embodiments, surface coverage may be in the range of 80%-100%, and / or any range or subrange therebetween.

[0064] In some embodiments, the passivation layer is a conformal layer. In some embodiments, the passivation layer is a layer having a substantially uniform thickness or a uniform thickness. In some embodiments, the passivation layer may be a corrosion-resistant layer or may form a corrosion-resistant 3D article surface. In some embodiments, the passivation layer may be an etch-resistant layer or may form an etch-resistant 3D article surface. In some embodiments, the passivation layer may passivate the surface of the 3D article. In some embodiments, the passivation layer may be a protective layer. In some embodiments, the passivation layer may impart at least one improved surface property.

[0065] In some embodiments, the passivation layer may have a thickness of 1 nm to 200 nm, or any range or subrange therebetween. For example, in some embodiments, the passivation layer may have a thickness of 5 nm to 200 nm, 10 nm to 200 nm, 25 nm to 200 nm, 50 nm to 200 nm, 100 nm to 200 nm, 150 nm to 200 nm, 1 nm to 150 nm, 25 nm to 150 nm, 50 nm to 150 nm, 100 nm to 150 nm, 25 nm to 130 nm, 50 nm to 130 nm, 75 nm to 130 nm, and / or any range or subrange therebetween. In some embodiments, the thickness of the passivation layer may be measured by scanning electron microscope (SEM) cross section, X-ray photoelectron spectroscopy (XPS) depth profiling, or energy-disruptive (EDAX) microanalysis, among other techniques.

[0066] Some embodiments provide an article formed according to any of the methods disclosed herein. For example, in some embodiments, the article may include an additively manufactured three-dimensional (3D) body and a passivation layer on a surface of the additively manufactured 3D body. It will be understood that the article may include any of the features disclosed herein.

[0067] FIG. 2 is a schematic diagram of a cross section of an article according to some embodiments of the present disclosure. As shown in FIG. 2, the article 200 may include an additively manufactured 3D body 202. The additively manufactured 3D body 202 may include a magnesium component. The article 200 may further include a passivation layer 204. In some embodiments, the passivation layer 204 may be at the surface and sub-surface of the additively manufactured 3D body 202. For example, in some embodiments, the passivation layer 204 may be a passivation region of the additively manufactured 3D body 202 that extends from the surface of the additively manufactured 3D body 202 to a depth within the additively manufactured 3D body 202. In some of these embodiments, the additively manufactured 3D body 202 may further include a bulk region 208, which is a region of the additively manufactured 3D body 202 that is not a region that defines the passivation layer 204. In some embodiments, the passivation layer 204 may include any surface portion that includes magnesium fluoride. That is, in some embodiments, magnesium fluoride is the reaction product of a magnesium component and a fluorine component from a reactive gas phase.

[0068] Article 200 may be characterized as being biocompatible. That is, for example, in some embodiments, article 200 is biocompatible. As used herein, the term "biocompatible" may refer to a material capable of functioning or existing in contact with biological fluids, tissues of biological entities, or any combination thereof, without having a deleterious effect on the biological entity. In some embodiments, the term "biocompatible" may refer to a material capable of functioning or existing in contact with biological fluids, tissues of biological entities, or any combination thereof, while having a net beneficial effect on the biological entity. Being biocompatible in some embodiments, article 200 may be particularly useful as a medical device or part of a medical device.

[0069] Thus, in some embodiments, the article 200 is a medical device. The medical device may include an additively manufactured 3D body, as well as surface and subsurface passivation layers of the additively manufactured 3D body. Any of the additively manufactured 3D bodies and passivation layers of the present disclosure may be used herein. For example, in some embodiments, the additively manufactured 3D body includes a magnesium component. In some embodiments, the passivation layer includes magnesium fluoride. In some embodiments, the magnesium fluoride is a reaction product of a magnesium component and a fluorine component from a reactive gas phase.

[0070] In some embodiments, the medical device is configured to be implanted in a mammal. In some embodiments, the medical device is configured to be temporarily inserted in a mammal. In some embodiments, the medical device is configured to be applied externally in a mammal. In some embodiments, the additively manufactured 3D body is biocompatible. In some embodiments, the additively manufactured 3D body is a body of a medical device. In some embodiments, the additively manufactured 3D body is a part of a medical device.

[0071] In some embodiments, the additively manufactured 3D body is at least one of a balloon, a graft, a stent, a catheter, a shunt, an embolic agent, a pacemaker, a defibrillator, an artificial implant, a prosthesis, a stimulator, a sensor, a wire, a lead, a valve, a plug, a pump, a filter, a mechanical connector, a tube, a plate, a surgical instrument, a housing, any part thereof, or any combination thereof. In some embodiments, the additively manufactured 3D body is at least one of an angioplasty balloon, a valvuloplasty balloon, a placement balloon, a pacemaker lead, a prosthetic heart valve, a vascular filter, a vascular plug, an artificial heart valve, an artificial heart, a catheter tip, a suture, a surgical stapler, a screw, a nail, a bracket, a pin, a rod, a fixator, a guidewire, a drug pump, a synthetic vascular graft, a vascular graft, a non-vascular graft, a stent graft, a vascular stent, a coronary stent, a peripheral stent, an intraluminal paving stent, an arteriovenous shunt, an aneurysm filling, an implantable pulse generator, an implantable cardiac defibrillator, an electrical defibrillator, a spinal cord stimulator, a brain stimulator, a sacral nerve stimulator, a bone prosthesis, a joint prosthesis, a plastic tube, a metal tube, a dental appliance, a hearing aid, a bandage, any part thereof, or any combination thereof.

[0072] In some embodiments, the additively manufactured 3D body comprises a structure having an aspect ratio between 2: 1 and 1000: 1. In some embodiments, the aspect ratio is the ratio of two of the width, depth, height, or diameter.

[0073] In some embodiments, the magnesium component comprises at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

[0074] In some embodiments, the additively manufactured 3D body has a monolithic structure that cannot be constructed by machining. In some embodiments, the additively manufactured 3D body is a one-piece constructed article. In some embodiments, the additively manufactured 3D body does not include seams. In some embodiments, the additively manufactured 3D body does not include brazed joints. In some embodiments, the additively manufactured 3D body does not include welded joints.

[0075] In some embodiments, the reactive gas phase comprises at least one of CF4, C2F4, C3F6, C4F8, CHF3, C2H2F2, C2F6, HF, CH3F, or any combination thereof. 10 It is derived from at least one of polymerized perfluoroalkyl ethylene having a perfluoroalkyl group; polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

[0076] FIG. 3 is a schematic diagram of an article according to some embodiments of the present disclosure. In some embodiments, the article 300 may be a component (e.g., structure, material, apparatus, equipment, etc.) used in a semiconductor or microelectronic fabrication apparatus, system, part, portion, equipment, or process. In some embodiments, the article 300 is a showerhead used to deliver process gases to a semiconductor wafer in a process chamber. As shown in FIG. 3, the article 300 may include an additively manufactured 3D support structure 302 that forms a cavity 304. In some embodiments, an opening 306 is formed in the cavity 304. In some embodiments, one or more process gases may flow through the opening 306 to the cavity 304. In some embodiments, the additively manufactured 3D support structure 302 further includes a plurality of holes 308 through which one or more process gases flow. As shown in FIG. 3, the showerhead component may include a passivation layer 310. In some embodiments, the passivation layer 310 is formed on all exposed surfaces of the showerhead component. EXAMPLES

[0077] Example 1 MgF2-Passivated Aluminum-Containing Additively Manufactured Articles Figures 4-5 are images of an additively manufactured article before the surface of the additively manufactured article shown in Figure 4 has been passivated, and after the surface of the additively manufactured article shown in Figure 5 has been passivated, according to some embodiments of the present disclosure. The additively manufactured articles of Figures 4-5 include aluminum. In Figure 5, the passivation layer is shown as having a darker surface than the unpassivated surface of the article shown in Figure 4.

[0078] 6-7 are graphs of energy dispersive X-ray spectroscopy (EDS) showing elemental spectra at a probing depth of about 250 nm, according to some embodiments of the present disclosure. The EDS spectra in FIG. 6-7 correspond to the additively manufactured articles shown in FIG. 4-5, respectively. In FIG. 6, no peaks corresponding to fluorine are detected, and the peaks corresponding to magnesium are low. In comparison to FIG. 6, as shown in FIG. 7, EDS detects both magnesium and fluoride in the region from the surface of the additively manufactured article to the probing depth, confirming the formation of magnesium fluoride. The increase in magnesium compared to FIG. 6 is a result of magnesium diffusion from the bulk of the additively manufactured article to the surface during the formation of the passivation layer. In some embodiments, the thickness of the magnesium fluoride surface layer was measured to be about 100 nm.

Claims

1. 1. A method for forming an article, comprising: forming a three-dimensional (3D) article by additive manufacturing to obtain an additively manufactured 3D article; The additively manufactured 3D article comprises a magnesium component. forming a three-dimensional (3D) article by additive manufacturing; exposing the additively manufactured 3D article to a reactive gas phase to form a passivation layer; The reactive gas phase includes a fluorine component, The fluorine component reacts with the magnesium component to form magnesium fluoride at the surface and subsurface of the additively manufactured 3D article; Exposing the additively manufactured 3D article to a reactive gas phase; A method comprising:

2. 10. The method of claim 1 , wherein forming comprises dispensing 3D printable material from a 3D printer to form the additively manufactured 3D article.

3. 3. The method of claim 1 or 2, wherein the magnesium component comprises at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

4. 4. The method of claim 1 , wherein the additively manufactured 3D article has a monolithic structure that cannot be constructed by machining.

5. 5. The method of claim 1 , wherein the additively manufactured 3D article is a monolithically constructed article.

6. 6. The method of any one of claims 1 to 5, wherein the additively manufactured 3D article comprises at least one of a plenum, a groove, a structure defining a hole, a structure defining a channel, a structure defining a cavity, or any combination thereof.

7. 7. The method of any one of claims 1 to 6, wherein the additively manufactured 3D article has an aspect ratio of 2:1 to 1000:1, the aspect ratio being the ratio of two of the following: width, depth, height, or diameter.

8. 8. The method of any one of claims 1 to 7, wherein the additively manufactured 3D article is seam-free.

9. 9. The method of any one of claims 1 to 8, wherein the additively manufactured 3D article does not include a brazed joint.

10. 10. The method of any one of claims 1 to 9, wherein the additively manufactured 3D article does not include weld joints.

11. The reactive gas phase is CF 4 , C 2 F 4 , C 3 F 6 , C 4 F 8 , C.H.F. 3 , C 2 H 2 F 2 , C 2 F 6 , H.F., C.H. 3 11. The method of claim 1 , further comprising at least one of: F; F; or any combination thereof.

12. The reactive gas phase is C 1 ~C 1012. The method of any one of claims 1 to 11, wherein the polymeric perfluoroalkyl ethylene having a perfluoroalkyl group is derived from at least one of: polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

13. 13. The method of any one of claims 1 to 12, wherein the magnesium fluoride covers at least 90% of a gas exposed surface of the additively manufactured 3D article.

14. 14. A component of a semiconductor manufacturing tool comprising an article formed by the method of any one of claims 1 to 13.

15. A medical device comprising an article formed by the method of any one of claims 1 to 13.

16. An article, an additively manufactured three-dimensional (3D) body; the additively manufactured 3D body comprises a magnesium component; The additively manufactured 3D body has a monolithic structure that cannot be constructed by machining; and a surface and subsurface passivation layer of an additively manufactured 3D body; the passivation layer comprises magnesium fluoride; Magnesium fluoride is a reaction product of magnesium components with fluorine components from the reactive gas phase, forming a passivation layer. Including, articles.

17. 17. The article of claim 16, wherein the additively manufactured 3D article comprises at least one of a plenum, a groove, a structure defining a hole, a structure defining a channel, a structure defining a cavity, or any combination thereof.

18. 18. The article of claim 16 or 17, wherein the additively manufactured 3D article has an aspect ratio of 2:1 to 1000:1, the aspect ratio being the ratio of two of the width, depth, height, or diameter.

19. 19. The article of any one of claims 16 to 18, wherein the additively manufactured 3D article is a monolithically constructed article.

20. 20. The article of any one of claims 16 to 19, wherein the additively manufactured 3D article does not include seams, does not include brazed joints, and does not include welded joints.

21. 1. An additively manufactured three-dimensional (3D) body, comprising: an additively manufactured 3D body, the additively manufactured 3D body comprising a magnesium component; and a surface and subsurface passivation layer of an additively manufactured 3D body; the passivation layer comprises magnesium fluoride; Magnesium fluoride is a reaction product of magnesium components with fluorine components from the reactive gas phase, forming a passivation layer.

23. A medical device comprising:

22. 22. The medical device of claim 21 configured to be implanted in a mammal.

23. 22. The medical device of claim 21 configured for temporary insertion into a mammal.

24. 22. The medical device of claim 21 adapted for external application in a mammal.

25. 25. The medical device of any one of claims 21 to 24, wherein the additively manufactured 3D body is biocompatible.

26. 26. The medical device of any one of claims 21 to 25, wherein the additively manufactured 3D body is a medical device body.

27. 26. The medical device of any one of claims 21 to 25, wherein the additively manufactured 3D body is a part of the medical device.

28. 28. The medical device of any one of claims 21 to 27, wherein the additively manufactured 3D body is at least one of a balloon, a graft, a stent, a catheter, a shunt, an embolic agent, a pacemaker, a defibrillator, an artificial implant, a prosthesis, a stimulator, a sensor, a wire, a lead, a valve, a plug, a pump, a filter, a mechanical connector, a tube, a plate, a surgical instrument, a housing, any part thereof, or any combination thereof.

29. 29. The medical device of any one of claims 21 to 28, wherein the additively manufactured 3D body is at least one of an angioplasty balloon, a valvuloplasty balloon, a placement balloon, a pacemaker lead, a prosthetic heart valve, a vascular filter, a vascular plug, an artificial heart valve, an artificial heart, a catheter tip, a suture, a surgical stapler, a screw, a nail, a bracket, a pin, a rod, a fixator, a guidewire, a drug pump, a synthetic vascular graft, a vascular graft, a non-vascular graft, a stent graft, a vascular stent, a coronary stent, a peripheral stent, an intraluminal paving stent, an arteriovenous shunt, an aneurysm filling, an implantable pulse generator, an implantable cardiac defibrillator, an electrical defibrillator, a spinal cord stimulator, a brain stimulator, a sacral nerve stimulator, a bone prosthesis, a joint prosthesis, a plastic tube, a metal tube, a dental appliance, a hearing aid, a bandage, any part thereof, or any combination thereof.

30. 30. The medical device of any one of claims 21 to 29, wherein the additively manufactured 3D body comprises a structure having an aspect ratio of from 2:1 to 1000:

1.

31. 31. The medical device of claim 30, wherein the aspect ratio is the ratio of two of the width, depth, height, or diameter.

32. 32. The medical device of any one of claims 21 to 31, wherein the magnesium component comprises at least one of a magnesium-containing metal alloy, magnesium ions, a magnesium-containing metal oxide, elemental magnesium, or any combination thereof.

33. 33. The medical device of any one of claims 21 to 32, wherein the additively manufactured 3D body has a monolithic structure that cannot be constructed by machining.

34. 34. The medical device of any one of claims 21 to 33, wherein the additively manufactured 3D body is a monolithically constructed article.

35. 35. The medical device of any one of claims 21 to 34, wherein the additively manufactured 3D body is seam-free.

36. 36. The medical device of any one of claims 21 to 35, wherein the additively manufactured 3D body does not include a brazed joint.

37. 37. The medical device of any one of claims 21 to 36, wherein the additively manufactured 3D body does not include welded joints.

38. The reactive gas phase is CF 4 , C 2 F 4 , C 3 F 6 , C 4 F 8 , C.H.F. 3 , C 2 H 2 F 2 , C 2 F 6 , H.F., C.H. 3 38. The medical device of any one of claims 21 to 37, comprising at least one of: F; F; or any combination thereof.

39. The reactive gas phase is C 1 ~C 1039. The medical device of any one of claims 21 to 38, derived from at least one of polymerized perfluoroalkyl ethylene having a perfluoroalkyl group; polytetrafluoroethylene (PTFE); tetrafluoroethylene / perfluoro(alkyl vinyl ether) copolymer (PFA); tetrafluoroethylene / hexafluoropropylene copolymer (FEP); tetrafluoroethylene / perfluoro(alkyl vinyl ether) / hexafluoropropylene copolymer (EPA); polyhexafluoropropylene; ethylene / tetrafluoroethylene copolymer (ETFE); polytrifluoroethylene; polyvinylidene fluoride (PVDF); polyvinyl fluoride (PVF); polychlorotrifluoroethylene (PCTFE); ethylene / chlorotrifluoroethylene copolymer (ECTFE); or any combination thereof.

Citation Information

Patent Citations

  • Corrosion-resistant aluminum alloy material and its manufacture

    JP1992066657A

  • Method for shaping three-dimensional shape of magnesium

    JP2002059258A

  • Aluminum surface processing method

    JP2019218620A

  • Method for producing lamination-molded body and method for producing the same

    JP2020143311A

  • Al-Mg-Si alloys for applications such as additive manufacturing

    JP2021504578A